Literature DB >> 27123880

Describing Differences in Survival Curves.

Rick Chappell1, Xiaotian Zhu2.   

Abstract

Mesh:

Year:  2016        PMID: 27123880     DOI: 10.1001/jamaoncol.2016.0001

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  8 in total

1.  Effects of Sodium-glucose Cotransporter 2 Inhibitors on Amputation, Bone Fracture, and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus Using an Alternative Measure to the Hazard Ratio.

Authors:  Masayuki Kaneko; Mamoru Narukawa
Journal:  Clin Drug Investig       Date:  2019-02       Impact factor: 2.859

2.  How Do the Accrual Pattern and Follow-Up Duration Affect the Hazard Ratio Estimate When the Proportional Hazards Assumption Is Violated?

Authors:  Miki Horiguchi; Michael J Hassett; Hajime Uno
Journal:  Oncologist       Date:  2018-09-10

Review 3.  Time-Matched Evaluation of Cardiovascular Risks Associated with Drugs for Type 2 Diabetes Mellitus.

Authors:  Masayuki Kaneko; Mamoru Narukawa
Journal:  Clin Drug Investig       Date:  2019-05       Impact factor: 2.859

4.  Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio.

Authors:  Kyongsun Pak; Hajime Uno; Dae Hyun Kim; Lu Tian; Robert C Kane; Masahiro Takeuchi; Haoda Fu; Brian Claggett; Lee-Jen Wei
Journal:  JAMA Oncol       Date:  2017-12-01       Impact factor: 31.777

5.  Statistical Test/Estimation Methods Used in Contemporary Phase III Cancer Randomized Controlled Trials with Time-to-Event Outcomes.

Authors:  Hajime Uno; Miki Horiguchi; Michael J Hassett
Journal:  Oncologist       Date:  2019-11-19

6.  Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?

Authors:  Theodore Karrison; Masha Kocherginsky
Journal:  Clin Trials       Date:  2018-03-04       Impact factor: 2.486

7.  Assessing Clinical Equivalence in Oncology Biosimilar Trials With Time-to-Event Outcomes.

Authors:  Hajime Uno; Deborah Schrag; Dae Hyun Kim; Dejun Tang; Lu Tian; Hope S Rugo; Lee-Jen Wei
Journal:  JNCI Cancer Spectr       Date:  2019-08-01

8.  Dynamic RMST curves for survival analysis in clinical trials.

Authors:  Jason J Z Liao; G Frank Liu; Wen-Chi Wu
Journal:  BMC Med Res Methodol       Date:  2020-08-27       Impact factor: 4.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.